Dry Eye Disease Market is estimated to be US$ 14.1 Billion by 2034 with a CAGR of 7.20% during the forecast period

Dry eyes occurs if an eye do not produce enough tears or can produce poor-quality tears. Stringy mucus in eyes, burning or scratchy sensation, blurred vision, sensitivity to light, difficulty in wearing contact lenses and others are the common symptoms of dry eye disease.

Growing prevalence of dry eye disease across globe has become major factor in target market growth. Further, advancement in product used for treating dry eye disorders and improved healthcare infrastructure has facilitated the demand for market growth.  Furthermore, rising geriatric population coupled with developing eye-related diseases is anticipated to increase the demand for Dry Eye Disease market growth.Dry Eye Disease Market was valued at US$ 7 Billion in 2024 and is projected to grow at a CAGR of 7.20% to reach US$ 14.1 Billion by 2034.

The report “Dry Eye Disease Market, By Disease Type (Aqueous Deficient Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By Product (Topical Corticosteroids, Cyclosporine, Oral Omega Supplements, Punctual Plugs, and Artificial Tears), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

 Key Highlights:

• In May 2023, the U.S. FDA (Food and Drug Administration) has approved Bausch Lomb’s first prescription drug ‘Miebo’ drops for dry eye disease. After the approval, the Bausch Lomb planned to launch Miebo in second half of this year.

Analyst View:

Rising adoption of unhealthy lifestyle and prolonged use of laptops, mobiles, and reduction in blinking rate of an individual across globe has contributed in target market growth. Presence of major players and growing market consolidation activities to launch new product to treat eye disorders is likely to propel Dry Eye Disease market growth. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on

“Dry Eye Disease Market, By Disease Type (Aqueous Deficient Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By Product (Topical Corticosteroids, Cyclosporine, Oral Omega Supplements, Punctual Plugs, and Artificial Tears), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Market Insights from the report:

Dry Eye Disease Market was valued at US$ 7 Billion in 2024 and is projected to grow at a CAGR of 7.20% to reach US$ 14.1 Billion by 2034. The Dry Eye Disease Market is segmented based on Disease Type, Product, Distribution Channel, and Region.

• Based on Disease Type, Dry Eye Disease Market is segmented into Aqueous Deficient Dry Eye Syndrome, Evaporative Dry Eye Syndrome.
• Based on Product, Dry Eye Disease Market is segmented into Topical Corticosteroids, Cyclosporine, Oral Omega Supplements, Punctual Plugs, and Artificial Tears.
• Based on Distribution Channel, Dry Eye Disease Market is segmented into Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
• By Region, the Dry Eye Disease Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Dry Eye Disease Market:

The prominent players operating in the Dry Eye Disease Market includes, AbbVie Inc., Johnson & Johnson Services Inc., Otsuka Pharmaceuticals Co. Ltd., Novartis AG, AFT Pharmaceuticals, OASIS Medical, Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Ltd., Bausch & Lomb, and Others.

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- [email protected]

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com